LCN2 and heart failure: Understanding the potential of NGAL as a diagnostic tool could not only enhance early detection but also improve the management of heart failure, especially in its early stages, when intervention can significantly alter the disease course.18 This study aims to evaluate NGAL levels as a biomarker for the early diagnosis of heart failure in patients who do not have of kidney disease.